BioRestorative Therapies BRTX
NASDAQ BRTX
$0.22 -0.01 (-2.48%)
As of: Aug 21, 2026 · 11:45 AM EDT

BioRestorative Therapies (BRTX) EBITDA Margin (QoQ) (2012 - 2025)

BioRestorative Therapies (BRTX) EBITDA Margin (QoQ) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.94 Bn 132.09 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.59 Bn 78.60 Bn 3.93 Bn
3 Argenx Se 65.67 Bn 60.49 Bn 1.37 Bn
4 Moderna 57.81 Bn 52.67 Bn 52.00 Mn
5 BeOne Medicines 42.25 Bn 37.15 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.76 Bn 28.45 Bn 992.69 Mn
7 BioNTech SE 28.41 Bn 10.02 Bn 668.28 Mn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn
9 Royalty Pharma 27.24 Bn 26.41 Bn -
10 BioRestorative Therapies 1.93 Mn -1.02 Mn 17,964.00

Historic Data

Download Data
DateValue
Dec 31, 2025 1.19 Mn
Sep 30, 2025 -3.03 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 -1.30 Mn
Dec 31, 2024 -523,378.00
Sep 30, 2024 179,181.00
Jun 30, 2024 896,989.00
Mar 31, 2024 494,675.00
Dec 31, 2023 -657,528.00
Sep 30, 2023 -528,033.00
Jun 30, 2023 1.36 Mn
Mar 31, 2023 10.81 Mn
Dec 31, 2022 -11.06 Mn
Sep 30, 2022 -938,549.00
Jun 30, 2022 2.51 Mn
Mar 31, 2022 4.86 Mn
Dec 31, 2021 -3.41 Mn
Sep 30, 2021 -2.24 Mn
Jun 30, 2021 5.99 Mn
Mar 31, 2021 -7.86 Mn